Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
281.97 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 261.59 - 431.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 281.97 | USD |
Bio Rad Laboratories (BIO) Options Flow Summary
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 274.20 | 284.88 | 268.3325 | 276.06 | 267,162 | 7.77 | 2.83% |
1 Month | 330.26 | 339.90 | 268.3325 | 286.17 | 224,609 | -48.29 | -14.62% |
3 Months | 322.00 | 364.24 | 268.3325 | 318.31 | 218,147 | -40.03 | -12.43% |
6 Months | 288.30 | 364.24 | 268.3325 | 314.47 | 235,438 | -6.33 | -2.20% |
1 Year | 384.25 | 431.79 | 261.59 | 338.35 | 226,270 | -102.28 | -26.62% |
3 Years | 607.05 | 832.70 | 261.59 | 462.88 | 189,794 | -325.08 | -53.55% |
5 Years | 303.78 | 832.70 | 261.59 | 455.06 | 200,372 | -21.81 | -7.18% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |